A simple supplement can improve survival in patients with a novel heart disease
Heart transplant is a scary and serious surgery with a high cost, but for patients with heart failure it can be the only ...
Novartis receives Health Canada approval for Fabhalta® oral treatment for adult patients with PNH
Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® (iptacopan ...